MEDI Group Limited (MEDG)

MEDI Group Income Statement

Financials in millions USD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2024	Jun 30, 2023
Revenue	5.51	6.11	8.02
Revenue Growth (YoY)	-	-23.82%	-
Cost of Revenue	-	1.3	1.65
Gross Profit	4.2	4.81	6.38
Selling, General & Admin	-	4.15	4.57
Operating Expenses	-	4.15	4.57
Operating Income	0.74	0.66	1.8
Interest Expense / Income	0.03	0.03	0.04
Other Expense / Income	0.02	0.01	-0.14
Pretax Income	0.69	0.61	1.9
Net Income	0.69	0.61	1.9
Net Income Growth	-	-68.02%	-
Free Cash Flow	-1.13	-1.19	-1.21
Gross Margin	76.33%	78.66%	79.48%
Operating Margin	13.48%	10.73%	22.47%
Profit Margin	12.60%	9.94%	23.69%
Free Cash Flow Margin	-20.45%	-19.55%	-15.07%
EBITDA	0.89	0.9	2.25
EBITDA Margin	16.12%	14.65%	27.98%
Depreciation & Amortization	0.16	0.25	0.3
EBIT	0.73	0.64	1.94
EBIT Margin	13.20%	10.51%	24.22%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).